Skip to main content
Erschienen in: Skeletal Radiology 9/2023

04.04.2023 | Scientific Article

Diagnostic value of machine learning-based computed tomography texture analysis for differentiating multiple myeloma from osteolytic metastatic bone lesions in the peripheral skeleton

verfasst von: Hakan Abdullah Özgül, Işıl Başara Akin, Uygar Mutlu, Ali Balci

Erschienen in: Skeletal Radiology | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To report the diagnostic performance of machine learning-based CT texture analysis for differentiating multiple myeloma from osteolytic metastatic bone lesions in the peripheral skeleton.

Methods

We retrospectively evaluated 172 patients with multiple myeloma (n = 70) and osteolytic metastatic bone lesions (n = 102) in the peripheral skeleton. Two radiologists individually used two-dimensional manual segmentation to extract texture features from non-contrast CT. In total, 762 radiomic features were extracted. Dimension reduction was performed in three stages: inter-observer agreement analysis, collinearity analysis, and feature selection. Data were randomly divided into training (n = 120) and test (n = 52) groups. Eight machine learning algorithms were used for model development. The primary performance metrics were the area under the receiver operating characteristic curve and accuracy.

Results

In total, 476 of the 762 texture features demonstrated excellent interobserver agreement. The number of features was reduced to 22 after excluding those with strong collinearity. Of these features, six were included in the machine learning algorithms using the wrapper-based classifier-specific technique. When all eight machine learning algorithms were considered for differentiating multiple myeloma from osteolytic metastatic bone lesions in the peripheral skeleton, the area under the receiver operating characteristic curve and accuracy were 0.776–0.932 and 78.8–92.3%, respectively. The k-nearest neighbors model performed the best, with the area under the receiver operating characteristic curve and accuracy values of 0.902 and 92.3%, respectively.

Conclusion

Machine learning-based CT texture analysis is a promising method for discriminating multiple myeloma from osteolytic metastatic bone lesions.
Literatur
1.
Zurück zum Zitat Roodman GD. Pathogenesis of myeloma bone disease. J Cell Biochem. 2010;109:283–91.PubMed Roodman GD. Pathogenesis of myeloma bone disease. J Cell Biochem. 2010;109:283–91.PubMed
2.
Zurück zum Zitat Panaroni C, Yee AJ, Raje NS. Myeloma and bone disease. Curr Osteoporos Rep. 2017;15:483–98.PubMed Panaroni C, Yee AJ, Raje NS. Myeloma and bone disease. Curr Osteoporos Rep. 2017;15:483–98.PubMed
3.
Zurück zum Zitat Hillengass J. Evolving concepts in the diagnosis and staging of multiple myeloma. J Natl Compr Cancer Netw. 2020;18:1770–2. Hillengass J. Evolving concepts in the diagnosis and staging of multiple myeloma. J Natl Compr Cancer Netw. 2020;18:1770–2.
4.
Zurück zum Zitat Roodman GD. Pathogenesis of myeloma bone disease. Leukemia. 2009;23:435–41.PubMed Roodman GD. Pathogenesis of myeloma bone disease. Leukemia. 2009;23:435–41.PubMed
5.
Zurück zum Zitat Terpos E, Dimopoulos MA, Moulopoulos LA. The role of imaging in the treatment of patients with multiple myeloma in 2016. Am Soc Clin Oncol Educ B. 2016;36:407–17. Terpos E, Dimopoulos MA, Moulopoulos LA. The role of imaging in the treatment of patients with multiple myeloma in 2016. Am Soc Clin Oncol Educ B. 2016;36:407–17.
7.
Zurück zum Zitat Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;15:1655–64. Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;15:1655–64.
8.
Zurück zum Zitat Giuliani N, Rizzoli V, Roodman GD. Multiple myeloma bone disease: patho-physiology of osteoblast inhibition. Blood. 2006;108:3992–6.PubMed Giuliani N, Rizzoli V, Roodman GD. Multiple myeloma bone disease: patho-physiology of osteoblast inhibition. Blood. 2006;108:3992–6.PubMed
9.
Zurück zum Zitat Terpos E, Ntanasis-Stathopoulos I, Gavriatopoulou M, et al. Pathogenesis of bone disease in multiple myeloma: from bench to bedside. Blood Cancer J. 2018;8:7.PubMedPubMedCentral Terpos E, Ntanasis-Stathopoulos I, Gavriatopoulou M, et al. Pathogenesis of bone disease in multiple myeloma: from bench to bedside. Blood Cancer J. 2018;8:7.PubMedPubMedCentral
10.
Zurück zum Zitat Bernstein ZS, Kim EB, Raje N. Bone disease in multiple myeloma: biologic and clinical implications. Cells. 2022;11(15):2308.PubMedPubMedCentral Bernstein ZS, Kim EB, Raje N. Bone disease in multiple myeloma: biologic and clinical implications. Cells. 2022;11(15):2308.PubMedPubMedCentral
11.
Zurück zum Zitat Clézardin P, Coleman R, Puppo M, et al. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev. 2021;101(3):797–855.PubMed Clézardin P, Coleman R, Puppo M, et al. Bone metastasis: mechanisms, therapies, and biomarkers. Physiol Rev. 2021;101(3):797–855.PubMed
12.
Zurück zum Zitat Chandra H, Chandra S, Verma SK. Multiple myeloma or metastatic carcinoma breast: diagnostic dilemma in a case presenting with lytic bony lesion. Breast Dis. 2015;35:199–201.PubMed Chandra H, Chandra S, Verma SK. Multiple myeloma or metastatic carcinoma breast: diagnostic dilemma in a case presenting with lytic bony lesion. Breast Dis. 2015;35:199–201.PubMed
13.
Zurück zum Zitat Tomono H, Fujioka S, Kato K, Yoshida K, Nimura Y. Multiple myeloma mimicking bone metastasis from breast cancer: report of a case. Surg Today. 1998;28:1304–6.PubMed Tomono H, Fujioka S, Kato K, Yoshida K, Nimura Y. Multiple myeloma mimicking bone metastasis from breast cancer: report of a case. Surg Today. 1998;28:1304–6.PubMed
14.
Zurück zum Zitat Hough B, Brufsky A, Lentzsch S. Metastatic breast cancer or multiple myeloma? Camouflage by lytic lesions. J Oncol. 2010;2010:7–9. Hough B, Brufsky A, Lentzsch S. Metastatic breast cancer or multiple myeloma? Camouflage by lytic lesions. J Oncol. 2010;2010:7–9.
15.
Zurück zum Zitat Kang YM, Lee HJ, Kim S-J. Metastatic breast cancer with osteolytic skull lesions suspected to be multiple myeloma. Korean J Clin Oncol. 2017;13:152–5. Kang YM, Lee HJ, Kim S-J. Metastatic breast cancer with osteolytic skull lesions suspected to be multiple myeloma. Korean J Clin Oncol. 2017;13:152–5.
16.
Zurück zum Zitat Hsu Y-T, Chang K-C. Breast cancer with extensive bone metastasis mimicking myeloma. Clin Case Reports. 2017;5:203–4. Hsu Y-T, Chang K-C. Breast cancer with extensive bone metastasis mimicking myeloma. Clin Case Reports. 2017;5:203–4.
17.
Zurück zum Zitat Zhang H, Lv J, Lv C, Zhang H. Presentation of multiple myeloma mimicking bone metastasis from colon adenocarcinoma: a case report and literature review. Mol Clin Oncol. 2016;4:31–4.PubMed Zhang H, Lv J, Lv C, Zhang H. Presentation of multiple myeloma mimicking bone metastasis from colon adenocarcinoma: a case report and literature review. Mol Clin Oncol. 2016;4:31–4.PubMed
18.
Zurück zum Zitat Merrild EH, Baerentzen S, Bouchelouche K, Buus S. Vertebral myeloma mimicking prostatic carcinoma metastasis in 68Ga-PSMA PET/CT. Clin Nucl Med. 2017;42:790–2.PubMed Merrild EH, Baerentzen S, Bouchelouche K, Buus S. Vertebral myeloma mimicking prostatic carcinoma metastasis in 68Ga-PSMA PET/CT. Clin Nucl Med. 2017;42:790–2.PubMed
19.
Zurück zum Zitat Shah E, Azhar W, Saleem S. A trail to diagnosis-finding the primary lesions of bone metastasis. Cureus. e2022;44:1–6 Shah E, Azhar W, Saleem S. A trail to diagnosis-finding the primary lesions of bone metastasis. Cureus. e2022;44:1–6
20.
Zurück zum Zitat Nagao T, Bando K, Iura A, et al. Malignant paraganglioma mimicking multiple myeloma. Rinsho Ketsueki Japan. 2022;63:1373–8. Nagao T, Bando K, Iura A, et al. Malignant paraganglioma mimicking multiple myeloma. Rinsho Ketsueki Japan. 2022;63:1373–8.
21.
Zurück zum Zitat Mutlu U, Balci A, Özsan GH, Özkal S, Şeyhanli A, Özgül HA. Computed tomography characteristics of multiple myeloma and other osteolytic metastatic bone lesions. Acta Radiol. 2021;62:1639–47.PubMed Mutlu U, Balci A, Özsan GH, Özkal S, Şeyhanli A, Özgül HA. Computed tomography characteristics of multiple myeloma and other osteolytic metastatic bone lesions. Acta Radiol. 2021;62:1639–47.PubMed
22.
Zurück zum Zitat Varghese BA, Cen SY, Hwang DH, et al. Texture analysis of imaging: what radiologists need to know. AJR Am J Roentgenol. 2019;212:520–8.PubMed Varghese BA, Cen SY, Hwang DH, et al. Texture analysis of imaging: what radiologists need to know. AJR Am J Roentgenol. 2019;212:520–8.PubMed
23.
Zurück zum Zitat Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278:563–77.PubMed Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2016;278:563–77.PubMed
25.
Zurück zum Zitat Kocak B, Kus EA, Yardimci AH, Bektas CT, Kilickesmez O. Machine learning in radiomic renal mass characterization: fundamentals, applications, challenges, and future directions. AJR Am J Roentgenol. 2020;215:920–8.PubMed Kocak B, Kus EA, Yardimci AH, Bektas CT, Kilickesmez O. Machine learning in radiomic renal mass characterization: fundamentals, applications, challenges, and future directions. AJR Am J Roentgenol. 2020;215:920–8.PubMed
26.
Zurück zum Zitat Gitto S, Cuocolo R, Albano D, et al. MRI radiomics-based machine-learning classification of bone chondrosarcoma. Eur J Radiol. 2020;128:109043.PubMed Gitto S, Cuocolo R, Albano D, et al. MRI radiomics-based machine-learning classification of bone chondrosarcoma. Eur J Radiol. 2020;128:109043.PubMed
27.
Zurück zum Zitat Basara Akin I, Ozgul H, Simsek K, Altay C, Secil M, Balci P. Texture analysis of ultrasound images to differentiate simple fibroadenomas from complex fibroadenomas and benign phyllodes tumors. J Ultrasound Med. 2020;39:1993–2003.PubMed Basara Akin I, Ozgul H, Simsek K, Altay C, Secil M, Balci P. Texture analysis of ultrasound images to differentiate simple fibroadenomas from complex fibroadenomas and benign phyllodes tumors. J Ultrasound Med. 2020;39:1993–2003.PubMed
28.
Zurück zum Zitat Jin Z, Wang Y, Wang Y, Mao Y, Zhang F. Application of 18F-FDG PET-CT images based radiomics in identifying vertebral multiple myeloma and bone metastases. Front Med. 2022;9:1–12. Jin Z, Wang Y, Wang Y, Mao Y, Zhang F. Application of 18F-FDG PET-CT images based radiomics in identifying vertebral multiple myeloma and bone metastases. Front Med. 2022;9:1–12.
29.
Zurück zum Zitat Baykara M, Yıldırım M. Differentiation of multiple myeloma and metastases with apparent diffusion coefficient map histogram analysis. North Clin Istanb. 2022;9:256–60.PubMedPubMedCentral Baykara M, Yıldırım M. Differentiation of multiple myeloma and metastases with apparent diffusion coefficient map histogram analysis. North Clin Istanb. 2022;9:256–60.PubMedPubMedCentral
30.
Zurück zum Zitat Tagliafico AS, Cea M, Rossi F, et al. Differentiating diffuse from focal pattern on computed tomography in multiple myeloma: added value of a radiomics approach. Eur J Radiol. 2019;121:108739.PubMed Tagliafico AS, Cea M, Rossi F, et al. Differentiating diffuse from focal pattern on computed tomography in multiple myeloma: added value of a radiomics approach. Eur J Radiol. 2019;121:108739.PubMed
31.
Zurück zum Zitat Park H, Lee S, Lee J, et al. Detecting multiple myeloma infiltration of the bone marrow on CT scans in patients with osteopenia : feasibility of radiomics analysis. Diagnostics. 2022;12:923.PubMedPubMedCentral Park H, Lee S, Lee J, et al. Detecting multiple myeloma infiltration of the bone marrow on CT scans in patients with osteopenia : feasibility of radiomics analysis. Diagnostics. 2022;12:923.PubMedPubMedCentral
32.
Zurück zum Zitat Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–48.PubMed Rajkumar SV, Dimopoulos MA, Palumbo A, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–48.PubMed
33.
Zurück zum Zitat Koçak B, Durmaz EŞ, Ateş E, Kılıçkesmez Ö. Radiomics with artificial intelligence: a practical guide for beginners. Diagn Interv Radiol. 2019;25:485–95.PubMedPubMedCentral Koçak B, Durmaz EŞ, Ateş E, Kılıçkesmez Ö. Radiomics with artificial intelligence: a practical guide for beginners. Diagn Interv Radiol. 2019;25:485–95.PubMedPubMedCentral
34.
Zurück zum Zitat Dormann CF, Elith J, Bacher S, et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography. 2013;36:27–46. Dormann CF, Elith J, Bacher S, et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography. 2013;36:27–46.
35.
Zurück zum Zitat Bermejo P, Gamez JA, Puerta JM. Improving incremental wrapper-based subset selection via replacement and early stopping. Int J Pattern Recognit Artif Intell. 2011;25:605–25. Bermejo P, Gamez JA, Puerta JM. Improving incremental wrapper-based subset selection via replacement and early stopping. Int J Pattern Recognit Artif Intell. 2011;25:605–25.
37.
Zurück zum Zitat Mwangi B, Tian TS, Soares JC. A review of feature reduction techniques in neuroimaging. Neuroinformatics. 2014;12:229–44.PubMedPubMedCentral Mwangi B, Tian TS, Soares JC. A review of feature reduction techniques in neuroimaging. Neuroinformatics. 2014;12:229–44.PubMedPubMedCentral
38.
Zurück zum Zitat Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics. 2006;7:91.PubMedPubMedCentral Varma S, Simon R. Bias in error estimation when using cross-validation for model selection. BMC Bioinformatics. 2006;7:91.PubMedPubMedCentral
39.
Zurück zum Zitat Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95:548–67.PubMed Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020;95:548–67.PubMed
42.
Zurück zum Zitat Li X, Wu N, Zhang W, Liu Y, Ming Y. Differential diagnostic value of 18F-FDG PET/CT in osteolytic lesions. J Bone Oncol. 2020;24:100302.PubMedPubMedCentral Li X, Wu N, Zhang W, Liu Y, Ming Y. Differential diagnostic value of 18F-FDG PET/CT in osteolytic lesions. J Bone Oncol. 2020;24:100302.PubMedPubMedCentral
43.
Zurück zum Zitat Lecouvet FE, Van Nieuwenhove S, Jamar F, Lhommel R, Guermazi A, Pasoglou VP. Whole-body MR imaging: the novel, “intrinsically hybrid,” approach to metastases, myeloma, lymphoma, in bones and beyond. PET Clin. 2018;13:505–22.PubMed Lecouvet FE, Van Nieuwenhove S, Jamar F, Lhommel R, Guermazi A, Pasoglou VP. Whole-body MR imaging: the novel, “intrinsically hybrid,” approach to metastases, myeloma, lymphoma, in bones and beyond. PET Clin. 2018;13:505–22.PubMed
44.
Zurück zum Zitat Matteucci F, Paganelli G, Martinelli G, Cerchione C. PET/CT in multiple myeloma: beyond FDG. Front Oncol. 2021;10:622501.PubMedPubMedCentral Matteucci F, Paganelli G, Martinelli G, Cerchione C. PET/CT in multiple myeloma: beyond FDG. Front Oncol. 2021;10:622501.PubMedPubMedCentral
46.
Zurück zum Zitat Mutlu İN, Koçak B, Ateş Kuş E, Baykara Ulusan M, Kılıçkesmez Ö. Machine learning-based computed tomography texture analysis of lytic bone lesions needing biopsy: a preliminary study. Istanbul Med J. 2021;22:223–31. Mutlu İN, Koçak B, Ateş Kuş E, Baykara Ulusan M, Kılıçkesmez Ö. Machine learning-based computed tomography texture analysis of lytic bone lesions needing biopsy: a preliminary study. Istanbul Med J. 2021;22:223–31.
47.
Zurück zum Zitat Ng F, Kozarski R, Ganeshan B, Goh V. Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol. 2013;82:342–8.PubMed Ng F, Kozarski R, Ganeshan B, Goh V. Assessment of tumor heterogeneity by CT texture analysis: can the largest cross-sectional area be used as an alternative to whole tumor analysis? Eur J Radiol. 2013;82:342–8.PubMed
Metadaten
Titel
Diagnostic value of machine learning-based computed tomography texture analysis for differentiating multiple myeloma from osteolytic metastatic bone lesions in the peripheral skeleton
verfasst von
Hakan Abdullah Özgül
Işıl Başara Akin
Uygar Mutlu
Ali Balci
Publikationsdatum
04.04.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 9/2023
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-023-04333-4

Weitere Artikel der Ausgabe 9/2023

Skeletal Radiology 9/2023 Zur Ausgabe

Test Yourself: Answer

Knee pain and swelling

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.